3SBio Inc logo

1530 - 3SBio Inc Share Price

HK$8.37 -0.3  -3.8%

Last Trade - 27/03/20

Sector
Healthcare
Size
Mid Cap
Market Cap £2.24bn
Enterprise Value £2.47bn
Revenue £585.7m
Position in Universe 398th / 5956
Bullish
Bearish
Unlock 1530 Revenue
Momentum
Relative Strength (%)
1m
3m
6m
1yr
Volume Change (%)
10d / 3m
Price vs... (%)
52w High
50d MA
200d MA
Margin of Safety
Qualifying GuruScreens
Health Trend(F-Score)
0 1 2 3 4 5 6 7 8 9
Bankruptcy Score(Z-Score)
Distress
Cautious
Safe
Earnings Manipulation Risk(M-Score)
Other Ratios
Recent History
Latest interim period vs. prior period Industry Market
3yr Compound Annual Growth Rate Industry Market
Graphical History

Revenue

1530 Revenue Unlock 1530 Revenue

Net Income

1530 Net Income Unlock 1530 Revenue

Normalised EPS

1530 Normalised EPS Unlock 1530 Revenue

PE Ratio Range

1530 PE Ratio Range Unlock 1530 Revenue

Dividend Yield Range

1530 Dividend Yield Range Unlock 1530 Revenue
Analyst Forecasts
Price Target:
( below Price)
31st Dec 2020
31st Dec 2021
Est. Long Term Growth Rate: Net Profit
()
EPS
()
DPS
()
Net Profit
()
EPS
()
DPS
()
Consensus Estimate
1m Change
3m Change
Analyst Consensus
Strong Sell Sell Hold Buy Strong Buy
EPS 2019 /  2020
1530 EPS Forecasts Unlock 1530 Revenue
Profile Summary

3SBio Inc. is an investment holding company mainly engaged in the the development, production, marketing and sale of pharmaceutical products. The Company’s main products include recombinant human thrombopoietin (rhTPO) products, tumor necrosis factor (TNF)αinhibitor products and recombinant human erythropoietin (rhEPO) products. The products are sold under the name of TPIAO, Yisaipu, EPIAO and SEPO. The Company distributes its products within the domestic market and to overseas markets, including Sri Lanka, Dominican Republic and Thailand. The Company’s subsidiaries include Collected Mind Limited, Hongkong Sansheng Medical Limited and Shenyang Sunshine Pharmaceutical Co., Ltd.. Through its subsidiaries, the Company is engaged in project management and consultation.

Directors
Last Annual December 31st, 2018
Last Interim June 30th, 2019
Incorporated August 9, 2006
Public Since June 11, 2015
No. of Shareholders: n/a
No. of Employees: 5,246
Sector Healthcare
Industry Pharmaceuticals
Index Hang Seng Composite , Hang Seng Composite LargeCap & MidCap , Hang Seng Mainland 100 , Hang Seng Composite MidCap ,
Exchange Stock Exchange of Hong Kong Limited
Shares in Issue 2,534,992,051
Free Float (0.0%)
Eligible for
ISAs
SIPPs
1530 Share Price Performance
Share Price
Bid - Ask
Low - High
Spread
Day's Change
Avg Volume
Open - Close
Range (12m)
Beta
Latest News for 1530
Upcoming Events for 1530
Friday 19th June, 2020 Estimate
3SBio Inc Annual Shareholders Meeting
Wednesday 19th August, 2020 Estimate
Half Year 2020 3SBio Inc Earnings Release
Similar to 1530
© Stockopedia 2020, Refinitiv, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.